4.1 Article

Rivaroxaban in the treatment of TEK-related venous malformation

Journal

AUSTRALASIAN JOURNAL OF DERMATOLOGY
Volume 63, Issue 3, Pages E255-E258

Publisher

WILEY
DOI: 10.1111/ajd.13856

Keywords

factor Xa inhibitors; genetic testing; mosaicism; quality of life; rivaroxaban; vascular malformations

Categories

Ask authors/readers for more resources

This case report presents a successful treatment of a venous malformation due to a variant in the TEK gene using low dose rivaroxaban, effectively controlling symptoms of chronic localized intravascular coagulation.
Low-flow vascular malformations are rare congenital anomalies due to errors in vascular development and may be associated with known pathogenic genetic variants. Slow flow through the blood vessels can lead to localized intralesional thromboses, which can cause debilitating pain and impair quality of life. We present a case of venous malformation due to a variant in the TEK gene in a 38-year-old woman in whom treatment with low dose rivaroxaban was successful in controlling symptoms of chronic localized intravascular coagulation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available